Abstract:Alpha-synuclein is an intrinsically disordered protein that accumulates in the brains of patients with Parkinson's disease and forms intraneuronal inclusions called Lewy Bodies. While the mechanism underlying the dysregulation of alpha-synuclein in Parkinson's disease is unclear, it is thought that prionoid cell-to-cell propagation of alpha-synuclein has an important role. Through a high throughput screen, we recently identified 38 genes whose knock down modulates alpha-synuclein propagation. Follow up experiments were undertaken for two of those genes, TAX1BP1 and ADAMTS19, to study the mechanism with which they regulate alpha-synuclein homeostasis. We used a recently developed M17D neuroblastoma cell line expressing triple mutant (E35K+E46K+E61K) "3K" alpha-synuclein under doxycycline induction. 3K alpha-synuclein spontaneously forms inclusions that show ultrastructural similarities to Lewy Bodies. Experiments using that cell line showed that TAX1BP1 and ADAMTS19 regulate how alpha-synuclein interacts with lipids and phase separates into inclusions, respectively, adding to the growing body of evidence implicating those processes in Parkinson's disease. Through RNA sequencing, we identified several genes that are differentially expressed after knock-down of TAX1BP1 or ADAMTS19. Burden analysis revealed that those differentially expressed genes (DEGs) carry an increased frequency of rare risk variants in Parkinson's disease patients versus healthy controls, an effect that was independently replicated across two separate cohorts (GP2 and AMP-PD). Weighted gene co-expression network analysis (WGCNA) showed that the DEGs cluster within modules in regions of the brain that develop high degrees of alpha-synuclein pathology (basal ganglia, cortex). We propose a novel model for the genetic architecture of sporadic Parkinson's disease: increased burden of risk variants across genetic networks dysregulates pathways underlying alpha-synuclein homeostasis, thereby leading to pathology and neurodegeneration.

Are rare heterozygous SYNJ1 variants associated with Parkinson's disease?

Are rare heterozygous variants associated with Parkinson’s disease?

Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease

A Novel Homozygous SYNJ1 Mutation in Two Siblings with Typical Parkinson's Disease.

Gene-based Burden Analysis of Damaging Private Variants in PRKN, PARK7 and PINK1 in Parkinson's Disease Cohorts of European Descent

Co-occurrence of PRKN and SYNJ1 variants in Early-Onset Parkinson's disease

Genetic Variants In The Rab7l1 And Slc41a1 Genes Of The Park16 Locus In Chinese Parkinson'S Disease Patients

Haplotype Analysis on the Relationship of the DNAJC6 Gene with Early-Onset Parkinson's Disease Risk in a Chinese Population.

Rare Variants Analysis of Lysosomal Related Genes in Early-Onset and Familial Parkinson's Disease in a Chinese Cohort

Low-frequency and rare coding variants of NUS1 contribute to pathogenesis and phenotype of Parkinson’s disease: a case-control study

Low-frequency and Rare Coding Variants of NUS1 Contribute to Susceptibility and Phenotype of Parkinson's Disease

<i>ANXA1</i> and the risk for early-onset Parkinson's disease

Genetic Analysis of ATP13A2, PLA2G6 and FBXO7 in a Cohort of Chinese Patients with Early-Onset Parkinson's Disease.

Case-control study of the UCH-L1 S18Y variant in sporadic Parkinson's disease in Chinese population

Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson's disease

Association of rare heterozygous PLA2G6 variants with the risk of Parkinson's disease

Synj1 Haploinsufficiency Causes Dopamine Neuron Vulnerability and Alpha-Synuclein Accumulation in Mice

Mutation Analysis Ofdnajcfamily Forearly-Onsetparkinson'S Disease In A Chinese Cohort

Variant in the 3′ Region of SNCA Associated with Parkinson’s Disease and Serum Α-Synuclein Levels

Rare Variant Analysis of PTRHD1 in Parkinson’s Disease in the Chinese Population

Analysis of rare Parkinson’s disease variants in millions of people